The Latest Headlines at American Banking and Market News
Sumitomo Mitsui Trust Holdings Inc. Acquires 19,662 Shares of Brandywine Realty Trust (NYSE:BDN)
Sumitomo Mitsui Trust Holdings Inc. increased its holdings in shares of Brandywine Realty Trust (NYSE:BDN – Free Report) by 10.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC.... More of this article »
Sumitomo Mitsui Trust Holdings Inc. Sells 7,460 Shares of Banco Santander-Chile (NYSE:BSAC)
Sumitomo Mitsui Trust Holdings Inc. cut its position in Banco Santander-Chile (NYSE:BSAC – Free Report) by 10.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional... More of this article »
Louisiana State Employees Retirement System Purchases New Stake in The Boston Beer Company, Inc. (NYSE:SAM)
Louisiana State Employees Retirement System purchased a new stake in The Boston Beer Company, Inc. (NYSE:SAM – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities &... More of this article »
Louisiana State Employees Retirement System Buys New Stake in Dynavax Technologies Co. (NASDAQ:DVAX)
Louisiana State Employees Retirement System bought a new stake in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.... More of this article »
Louisiana State Employees Retirement System Makes New Investment in The Andersons, Inc. (NASDAQ:ANDE)
Louisiana State Employees Retirement System purchased a new position in The Andersons, Inc. (NASDAQ:ANDE – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 15,900... More of this article »
Louisiana State Employees Retirement System Takes Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Louisiana State Employees Retirement System purchased a new stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund... More of this article »
Barrington Research Reiterates “Outperform” Rating for Option Care Health (NASDAQ:OPCH)
Option Care Health (NASDAQ:OPCH – Get Free Report)‘s stock had its “outperform” rating restated by analysts at Barrington Research in a report released on Wednesday, Benzinga reports. They presently have a $38.00... More of this article »
PulteGroup (NYSE:PHM) Stock Rating Upgraded by Zelman & Associates
PulteGroup (NYSE:PHM – Get Free Report) was upgraded by investment analysts at Zelman & Associates from a “neutral” rating to an “outperform” rating in a report issued on Wednesday, Benzinga reports. A... More of this article »
First Bank (NASDAQ:FRBA) Price Target Cut to $15.00
First Bank (NASDAQ:FRBA – Get Free Report) had its target price decreased by stock analysts at Piper Sandler from $16.00 to $15.00 in a report released on Wednesday, Benzinga reports. The firm presently has an “overweight”... More of this article »
Halliburton (NYSE:HAL) Stock Rating Reaffirmed by Benchmark
Halliburton (NYSE:HAL – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Benchmark in a report issued on Wednesday, Benzinga reports. They presently have a $45.00 target price... More of this article »
DraftKings (NASDAQ:DKNG) Stock Rating Reaffirmed by Benchmark
DraftKings (NASDAQ:DKNG – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Benchmark in a report released on Wednesday, Benzinga reports. They presently have a $50.00 price... More of this article »
Enterprise Financial Services (NASDAQ:EFSC) PT Lowered to $49.00
Enterprise Financial Services (NASDAQ:EFSC – Get Free Report) had its price objective cut by research analysts at Keefe, Bruyette & Woods from $51.00 to $49.00 in a research report issued to clients and investors on Wednesday,... More of this article »
Keefe, Bruyette & Woods Lowers NBT Bancorp (NASDAQ:NBTB) Price Target to $39.00
NBT Bancorp (NASDAQ:NBTB – Get Free Report) had its price objective dropped by analysts at Keefe, Bruyette & Woods from $41.00 to $39.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has a... More of this article »